Biomedical Counsel
Mr. Chiang has long been dedicated to the research on proteins and antibodies. He once joined hands with the Institute of Applied Mechanics and the National Taiwan University in publishing relevant innovations in immunology technology, and participated in the development of new reagents during the period of COVID-19. Additionally, he was once included in the Chollima Program of the Ministry of Science and Technology, and went to the City of Hope, Los Angeles Cancer Medical Center as a visiting scholar to learn relevant gene editing technology. He is currently serving as a senior researcher in a biomedical company and a regulatory staff in a medical material company, with expertise in relevant R&D procedures and the certification of medical materials.
PhD of Biochemical Science & Technology, National Taiwan University
Master of Biochemical Science & Technology, National Taiwan University
Bachelor of Life Sciences, NCHU
Winnoz Technology, Inc.
Acheloy Biomed
Biochemistry
Molecular biology
Protein/antibody purification and application
Innovation and application of immunology technology
Research on emerging infectious diseases and development of diagnostic reagents
Certification and application of medical materials overseas
2022/07/01 | 回顧美國FDA醫療器材安全行動計畫-推動醫療器材網路安全 |
2022/06/30 | 巨群官網生醫短文6月份稿件 |
2022/05/20 | 數位醫療下的網路安全-從美國FDA的觀點出發 |